Zobrazeno 1 - 10
of 39
pro vyhledávání: '"B E Ryman"'
Publikováno v:
Journal of the Chemical Society. (6)
Publikováno v:
Journal of the Chemical Society. (6)
Publikováno v:
The Biochemical journal. 41(2)
Publikováno v:
Journal of the Chemical Society. (6)
Autor:
B. E. Ryman
Publikováno v:
Journal of Clinical Pathology. :106-121
Autor:
B E Ryman, V J Richardson
Publikováno v:
British Journal of Cancer
A TLX-5 mouse lymphoma which was resistant to 1-β-D-arabinofuranosyl cytosine (AraC) was used in vivo to study the possibility of using liposomes as drug-delivery vehicles in order to overcome drug resistance. The effects of free drugs (AraC, AraCTP
Publikováno v:
Bioscience Reports. 3:39-46
Heparin causes lysis of the multilamellar liposomes of all three charges, positive, neutral, and negative, and thus releases the entrapped [3H]glucose or chromate. The lytic effect of heparin is also observed in liposomes prepared from the lipids ext
Autor:
B. E. Ryman, Kd Bagshawe, B.E Jones, G.M Barratt, R. H. J. Begent, Frances Searle, A. J. Green, R. F. Jewkes, PA Keep
Publikováno v:
The Lancet. 320:739-742
The usefulness of antibodies directed against tumour products for localisation and therapy of cancer is limited by the large proportion of administered antibody which remains non-specifically in the circulation and extravascular space. Liposomally en
Publikováno v:
Diabetes. 31:506-511
Autor:
Stan B. Kaye, R. F. Jewkes, V. J. Richardson, B. E. Ryman, M.H.N. Tattersall, Edward S. Newlands, K. Jeyasingh
Publikováno v:
British Journal of Cancer
The possible use of liposomes (phospholipid vesicles) to direct cytotoxic drugs to tumours has led us to investigate the tissue localization of i.v. injected 99m-Tc-labelled liposomes in cancer patients. Twenty mg or 300 mg doses of liposomal lipid (